Generic Name |
Plocabulin + Gemcitabine | |
---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
||
Delivery |
Intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
GIST Tumor Based | |
Strategy |
Inhibit Tubulin and limit DNA replication | |
Drug Category |
Tubulin inhibotor + Chemotherapy |
Links |
|
Trials of this drug |
|
|
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors |
Trial results |